MEREDITH ALFORD: Open Payments
NPI 1932659257 · SAN MARCOS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 25 payments from 13 companies in 2025. Trend: 2023 $641 · 2024 $673 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $86 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $73 |
| Amgen Inc. | 4 | $66 |
| Alnylam Pharmaceuticals Inc. | 2 | $60 |
| Abbott Laboratories | 2 | $50 |
| Novo Nordisk Inc | 2 | $42 |
| AtriCure, Inc. | 1 | $31 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: LEQVIO, LifeVest, REPATHA, CARDIOMEMS, Ozempic, AMVUTTRA, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, ONPATTRO.
Industry payments across TX — which companies pay providers there.
